Position in AKBA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$306,704
+$148,180 QoQ
Shares Held
269,040
+135.9% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,243 across 61 Drug Manufacturers - Specialty & Generic names. AKBA ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in AKBA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,704 | 269,040 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $158,524 | 114,047 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $312,380 | 194,026 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,714,113 | 994,181 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $6,015,994 | 1,652,746 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,423,027 | 741,161 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $866,957 | 456,294 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $130,079 | 98,546 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $90,661 | 88,884 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $422 | 231 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $286 | 231 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $108,127 | 94,849 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,680 | 37,903 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $45,665 | 81,547 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2 | 4,044 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,599 | 11,391 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,548 | 7,220 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,057,384 | 4,258,198 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $10,016,776 | 4,432,203 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,149,315 | 4,565,735 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,752,072 | 4,947,777 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,072,210 | 1,203,017 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,084,706 | 1,458,824 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $572,156 | 227,951 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,175,042 | 233,803 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,638,375 | 479,997 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||